Background/Objectives: Autism is a complex neurodevelopmental disorder characterized by restricted behaviors and impaired social and communication skills. The exact cause of autism remains unknown. One promising animal model for studying autism is the valproic acid rat model. Due to a 1 to 4 bias for males in autism occurrence, most animal model studies investigate only males and neglect females. However, female autism often appears different from that observed in males. Females are said to be less regularly diagnosed because they can “mask” their symptoms. Female autism is as necessary to investigate as male autism. Methods: Fertile adult female Sprague-Dawley rats were impregnated and injected with valproic acid on gestational day 13. Male and female offspring were subjected to behavioral tests to investigate autistic symptoms. Tests included novel object recognition, balance-beam, Y-maze, hole-board, three-chamber, marble burying, olfactory, light/dark and hot plate tests. Results: The tests revealed that VPA-exposed rats had increased anxiety-like behaviors, hyperactivity, and impaired non-verbal communication. However, they did not display repetitive behaviors or cognitive impairments. Notably, male and female rats showed different autism-like traits, with both showing hyperactivity, and males (but not females) additionally showing impaired sociability and increased anxiety. Conclusions: The findings suggest that prenatal exposure to VPA induces autism-like behaviors in both male and female Sprague-Dawley rat offspring. However, males appear more impacted by VPA exposure as evinced by their display of more autism-like symptoms relative to females. This study provides support for including both sexes in all studies modelling autism, as outcomes are seemingly impacted by the sex being observed.
The phylogenetic contextualization of human neuroanatomy is crucial for understanding the positive, neutral, and/or negative effects of therapeutic interventions derived from animal models. Here we determined the parcellation of, and quantified, orexinergic (or hypocretinergic) neurons in the hypothalami of humans and several species of primates, including strepsirrhines (two species), platyrrhines (two species), cercopithecoids (three species), and hominoids (three species, including humans). The strepsirrhines, platyrrhines, and cercopithecoids presented with three distinct clusters of orexinergic neurons, revealing an organization like that observed in most mammals. In the three hominoids, an additional orexinergic cluster was found in the tuberal region of the hypothalamus, termed the optic tract cluster extension. In humans only, an additional parvocellular cluster of orexinergic neurons was observed in the dorsomedial hypothalamus. The human presented with the most complex parcellation of orexinergic neurons of the primates studied. Total numbers of orexinergic neurons in nonhuman primates were strongly correlated to brain mass (P uncorr = 1.2 × 10−6), with every doubling in brain mass leading to an ∼1.5‐times increase in neuron number. In contrast, humans have approximately 74,300 orexinergic neurons, which is significantly less than the 205,000 predicted using the nonhuman primate regression for a brain mass of ∼1363 g. We conclude that although the human orexinergic system is the most complex of primates in terms of parcellation, with potential associated functional specializations, this system is quantitatively paradoxical in having a significantly lower neuronal number than expected for a primate with an ∼1363‐g brain.
26 February 2025 in Journal of Comparative Neurology
The phylogenetic contextualization of human neuroanatomy is crucial for understanding the positive, neutral, and/or negative effects of therapeutic interventions derived from animal models. Here we determined the parcellation of, and quantified, orexinergic (or hypocretinergic) neurons in the hypothalami of humans and several species of primates, including strepsirrhines (two species), platyrrhines (two species), cercopithecoids (three species), and hominoids (three species, including humans). The strepsirrhines, platyrrhines, and cercopithecoids presented with three distinct clusters of orexinergic neurons, revealing an organization like that observed in most mammals. In the three hominoids, an additional orexinergic cluster was found in the tuberal region of the hypothalamus, termed the optic tract cluster extension. In humans only, an additional parvocellular cluster of orexinergic neurons was observed in the dorsomedial hypothalamus. The human presented with the most complex parcellation of orexinergic neurons of the primates studied. Total numbers of orexinergic neurons in nonhuman primates were strongly correlated to brain mass (Puncorr = 1.2 × 10−6), with every doubling in brain mass leading to an ∼1.5‐times increase in neuron number. In contrast, humans have approximately 74,300 orexinergic neurons, which is significantly less than the 205,000 predicted using the nonhuman primate regression for a brain mass of ∼1363 g. We conclude that although the human orexinergic system is the most complex of primates in terms of parcellation, with potential associated functional specializations, this system is quantitatively paradoxical in having a significantly lower neuronal number than expected for a primate with an ∼1363‐g brain.